{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:43:12Z","timestamp":1793281392869,"version":"4.5.0"},"reference-count":56,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Medical Devices"],"DOI":"10.1080\/17434440.2026.2753843","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:56:08Z","timestamp":1792637768000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The clinical laboratory as a missing stakeholder in Japan\u2019s program medical device (SaMD) framework: regulation, two-step approval, and the analytical-validation bridge"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-4991","authenticated-orcid":false,"given":"Koichiro","family":"Yuji","sequence":"first","affiliation":[{"name":"The Institute of Medical Science, the University of Tokyo (IMSUT)","place":["Tokyo, Japan"]},{"name":"Kitasato Institute Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Yuji","sequence":"additional","affiliation":[{"name":"Kitasato Institute Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,29]]},"reference":[{"key":"e_1_3_7_3_1","unstructured":"International Medical Device Regulators Forum. Software as a medical device (SaMD): key definitions. IMDRF\/SaMD WG\/N10;2013."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01800-1"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01312-x"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-026-02692-5"},{"key":"e_1_3_7_7_1","volume-title":"Software as a medical device (SaMD) [Internet]","author":"Pharmaceuticals and Medical Devices Agency","unstructured":"Pharmaceuticals and Medical Devices Agency. Software as a medical device (SaMD) [Internet]. Tokyo: PMDA; [cited 2026 Oct 22]. Available from: https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/0009.html"},{"key":"e_1_3_7_8_1","unstructured":"Ministry of Health Labour and Welfare. Handling of two-step approval reflecting the characteristics of program medical devices. Notification No. 1116-2. 2023 Nov 16. Japanese. [cited 2026 Aug 29]. Available from: https:\/\/www.pmda.go.jp\/review-services\/drug-reviews\/about-reviews\/devices\/0052.html"},{"key":"e_1_3_7_9_1","unstructured":"CureApp Inc. CureApp AUD (product name HAUDY): a drinking-reduction therapeutic-support app for alcohol use disorder; marketing approval no. 30700BZX00034000 granted by the Ministry of Health Labour and Welfare on 13 February 2025 (manufacturer CureApp Inc.; distributor Sawai Pharmaceutical Co. Ltd.). 2025."},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01317-8"},{"key":"e_1_3_7_11_1","unstructured":"Ministry of Health Labour and Welfare. Guideline on the medical-device applicability (device qualification) of programs. 2021 Mar 31 partial amendment 2023 Mar 31. Japanese. [cited 2026 Aug 29]. Available from https:\/\/www.pmda.go.jp\/files\/000240233.pdf"},{"key":"e_1_3_7_12_1","unstructured":"International Medical Device Regulators Forum. Software as a medical device: possible framework for risk categorization and corresponding considerations. IMDRF\/SaMD WG\/N12; 2014."},{"key":"e_1_3_7_13_1","unstructured":"International Medical Device Regulators Forum. Software as a medical device (SaMD): application of quality management system. IMDRF\/SaMD WG\/N23; 2015."},{"key":"e_1_3_7_14_1","unstructured":"Pharmaceuticals and Medical Devices Agency. Program medical devices (SaMD) \u00d7 real-world data: the present state\u2014PMDA symposium series (4 sessions February\u2013March 2026 including a session on the medical use of generative AI). [cited 2026]. Available from: https:\/\/www.pmda.go.jp\/review-services\/drug-reviews\/about-reviews\/devices\/0048.html"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0355"},{"key":"e_1_3_7_16_1","unstructured":"US Food and Drug Administration. Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions. FDA; final Dec 2024 (updated Aug 2025)."},{"key":"e_1_3_7_17_1","unstructured":"US FDA Health Canada MHRA. Predetermined change control plans for machine learning-enabled medical devices: guiding principles. 2023."},{"key":"e_1_3_7_18_1","unstructured":"US FDA Health Canada MHRA. Good machine learning practice for medical device development: guiding principles. 2021."},{"key":"e_1_3_7_19_1","unstructured":"European Parliament and Council of the European Union. Regulation (EU) 2024\/1689 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). Off J Eur Union. 2024."},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-0482"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1049\/ic:20060141"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa170"},{"key":"e_1_3_7_23_1","volume-title":"ISO 15189:2022 medical laboratories \u2014 requirements for quality and competence","author":"ISO","year":"2022","unstructured":"ISO. ISO 15189:2022 medical laboratories \u2014 requirements for quality and competence. Geneva: ISO; 2022."},{"key":"e_1_3_7_24_1","volume-title":"ISO 17511:2020 in vitro diagnostic medical devices \u2014 requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples","author":"ISO","year":"2020","unstructured":"ISO. ISO 17511:2020 in vitro diagnostic medical devices \u2014 requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples. Geneva: ISO; 2020."},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-0067"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1201"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1257"},{"key":"e_1_3_7_28_1","volume-title":"Implementation of metrological traceability in laboratory medicine","author":"Clinical and Laboratory Standards Institute","year":"2025","unstructured":"Clinical and Laboratory Standards Institute. Implementation of metrological traceability in laboratory medicine. 2nd ed. CLSI document EP32-Ed2. Berwyn (PA): Clinical and Laboratory Standards Institute; 2025.","edition":"2"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2024.0323"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-0182"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.4.624"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-1016"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0260-4"},{"key":"e_1_3_7_34_1","unstructured":"International Medical Device Regulators Forum. Software as a medical device (SaMD): clinical evaluation. IMDRF\/SaMD WG\/N41; 2017."},{"key":"e_1_3_7_35_1","volume-title":"Software as a medical device (SAMD): clinical evaluation \u2014 guidance for industry and FDA staff","author":"US Food and Drug Administration","year":"2017","unstructured":"US Food and Drug Administration. Software as a medical device (SAMD): clinical evaluation \u2014 guidance for industry and FDA staff. FDA; 2017."},{"key":"e_1_3_7_36_1","unstructured":"Centers for Disease Control and Prevention. ACCE model process for evaluating genetic tests. CDC Office of Public Health Genomics; Model Project 2000\u20132004."},{"key":"e_1_3_7_37_1","first-page":"217","volume-title":"Human genome epidemiology: a Scientific foundation for using genetic information to improve health and prevent disease","author":"Haddow JE","year":"2003","unstructured":"Haddow JE, Palomaki GE. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury MJ, Little J, Burke W, editors. Human genome epidemiology: a Scientific foundation for using genetic information to improve health and prevent disease. Oxford: Oxford University Press; 2003. p. 217\u2013233."},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318184137c"},{"key":"e_1_3_7_39_1","volume-title":"Addressing challenges in genetic test evaluation: evaluation frameworks and assessment of analytic validity","author":"Sun F","year":"2011","unstructured":"Sun F, Bruening W, Erinoff E, et al. Addressing challenges in genetic test evaluation: evaluation frameworks and assessment of analytic validity. Rockville (MD): Agency for Healthcare Research and Quality; 2011."},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000179941.44494.73"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1455"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01369-1"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvad055"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-1151"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01085-w"},{"key":"e_1_3_7_46_1","volume-title":"IEC 81001-5-1:2021\u00a0health software and health IT systems safety, effectiveness and security \u2014 Part 5-1: security \u2014 activities in the product life cycle","author":"IEC","year":"2021","unstructured":"IEC. IEC 81001-5-1:2021\u00a0health software and health IT systems safety, effectiveness and security \u2014 Part 5-1: security \u2014 activities in the product life cycle. Geneva: IEC; 2021."},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03203-3"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2626"},{"key":"e_1_3_7_49_1","volume-title":"ISO\/IEC 17043:2023 conformity assessment \u2014 general requirements for the competence of proficiency testing providers","author":"ISO\/IEC","year":"2023","unstructured":"ISO\/IEC. ISO\/IEC 17043:2023 conformity assessment \u2014 general requirements for the competence of proficiency testing providers. Geneva: ISO\/IEC; 2023."},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00611-y"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26930"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/AIra2400657"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-24-00042"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.2196\/50437"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2014-0142"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0412"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvae126"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-1030"}],"container-title":["Expert Review of Medical Devices"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17434440.2026.2753843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17434440.2026.2753843","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17434440.2026.2753843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:21:02Z","timestamp":1793280062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17434440.2026.2753843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,29]]},"references-count":56,"alternative-id":["10.1080\/17434440.2026.2753843"],"URL":"https:\/\/doi.org\/10.1080\/17434440.2026.2753843","relation":{},"ISSN":["1743-4440","1745-2422"],"issn-type":[{"value":"1743-4440","type":"print"},{"value":"1745-2422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}